Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy

U. Kopylov*, J. Hanzel, C. Liefferinckx, D. De Marco, N. Imperatore, N. Plevris, I. Baston-Rey, R.J. Harris, M. Truyens, V. Domislovic, S. Vavricka, V. Biemans, S. Myers, S. Sebastian, S. Ben-Horin, Y.G. Lama, C. Gilletta, B.G.S. Ariella, Z. Zelinkova, R. WeishofD. Storan, E. Zittan, K. Farkas, T. Molnar, D. Franchimont, A. Cremer, W. Afif, F. Castiglione, C. Lees, M. Barreiro-de Acosta, T. Lobaton, G. Doherty, Z. Krznaric, M. Pierik, F. Hoentjen, D. Drobne

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Web of Science)
Original languageEnglish
Pages (from-to)135-142
Number of pages8
JournalAlimentary Pharmacology & Therapeutics
Issue number1
Publication statusPublished - 1 Jul 2020


  • experience
  • induction

Cite this